Ramky Infrastructure Reports ₹250 Cr PAT in FY26, Q4 Profit Recovers
Ramky Infrastructure reported consolidated PAT of over ₹250 Cr for FY26, with revenue of ₹1,846 Cr and an order book of ₹13,000 Cr. Q4 consolidated net profit recovered to 429m Rupees from a loss of 133m Rupees YoY, while standalone PAT surged to ₹154 Cr driven by an exceptional gain from the sale of a stake in Visakha Pharma City Ltd. The company secured major projects including a ₹3,000 Cr Life Sciences City contract and a ₹2,085 Cr water transmission project during the year.

*this image is generated using AI for illustrative purposes only.
Ramky Infrastructure reported a consolidated profit after tax (PAT) of over ₹250 Cr for the financial year ended March 31, 2026. The company achieved a revenue of ₹1,846 Cr and maintained an order book of ₹13,000 Cr, reflecting its operational scale. The infrastructure firm also posted a standalone PAT of ₹250+ Cr for the same period, bolstered by an exceptional gain arising from the sale of an equity stake in its subsidiary, Visakha Pharma City Ltd.
The company's order inflow for FY26 stood at ₹6,500 Cr on a consolidated basis, while standalone order inflow was ₹3,000 Cr. Ramky Infrastructure reported a return on equity (ROE) of 13% for the consolidated entity and 20% on a standalone basis. The term debt position was recorded at ₹160 Cr consolidated, while the standalone entity maintained a nil term debt status.
Consolidated Operational Performance
On a consolidated basis, Q4 revenue stood at 5b Rupees compared to 4.9b Rupees in the same quarter of the previous year. Net profit for Q4 came in at 429m Rupees, reversing a loss of 133m Rupees reported in the year-ago period. EBITDA for the quarter stood at ₹11 Cr, a significant recovery from the negative ₹30 Cr reported in Q4FY25. Profit before tax (PBT) for Q4FY26 was ₹40 Cr, against a loss of ₹35 Cr in the prior year quarter.
| Metric (₹ in Cr) | Q4FY25 | Q4FY26 |
|---|---|---|
| Revenue | 465 | 507 |
| EBITDA | -30 | 11 |
| PBT | -35 | 40 |
| PAT | -53 | 52 |
Standalone Financials
On a standalone basis, revenue for Q4FY26 was ₹427 Cr, down from ₹486 Cr in Q4FY25. However, profitability improved sharply with PAT rising to ₹154 Cr from ₹9 Cr in the same quarter last year. This increase was driven by the exceptional item related to the subsidiary stake sale. EBITDA for the quarter stood at ₹19 Cr, compared to ₹45 Cr in the previous year.
| Metric (₹ in Cr) | Q4FY25 | Q4FY26 |
|---|---|---|
| Revenue | 486 | 427 |
| EBITDA | 45 | 19 |
| PBT | 12 | 149 |
| PAT | 9 | 154 |
Key Business Updates
During the year, Ramky Infrastructure secured significant projects, including a ₹3,000 crore Life Sciences City project awarded by Maharashtra Industrial Development Corporation. The company also won a ₹2,085 crore water transmission project from HMWSSB and a ₹1,401 crore EPC + O&M contract from Maharashtra Industrial Township Limited for the Dighi Port Industrial Area.
Historical Stock Returns for Ramky Infrastructure
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.63% | +0.53% | -12.33% | -24.77% | -4.32% | +388.73% |
How will the sale of the equity stake in Visakha Pharma City Ltd impact Ramky Infrastructure's long-term revenue streams?
What are the expected execution timelines for the newly secured ₹3,000 crore Life Sciences City project and other major contracts?
With a term debt of only ₹160 Cr, does Ramky Infrastructure plan to leverage its strong balance sheet for further acquisitions or expansion?


































